“…Highlighting the importance of these enzymes, mutations in human HR helicases that regular HR result in diseases such as Rothmund-Thompson syndrome and Fanconi Anemia, which are characterized by genome instability and increased incidence of cancer (Brosh, 2013). Srs2 is considered a proto-typical antirecombinase due to its well-characterized ability to remove Rad51 from ssDNA (Antony et al, 2009; Krejci et al, 2003; Marini and Krejci, 2010; Niu and Klein, 2016; Qiu et al, 2013; Sasanuma et al, 2013; Vasianovich et al, 2017; Veaute et al, 2003). Deletion of the SRS2 gene results in an increase in recombination frequency, and its importance is further revealed in Δsrs2 Δsgs1 and Δsrs2 ΔRad54 double mutants, which have a synthetic lethal phenotype due the accumulation of toxic recombination intermediates (Ira et al, 2003; Klein, 2001).…”